Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion type Assertion NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_head.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion evidence source_evidence_literature NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion SIO_000772 23806066 NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion wasDerivedFrom befree-2016 NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.
- NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion wasGeneratedBy ECO_0000203 NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.